Imagine a pivotal government agency tasked with safeguarding public health, suddenly thrust into a storm of political pressure and public scrutiny over its leadership decisions, creating a challenging environment for decision-making. This is the reality for the Food and Drug Administration (FDA) as
Imagine a system where the health of nursing home residents, some of the most vulnerable individuals in society, might be compromised for the sake of corporate profits. This unsettling scenario has come to light with allegations against UnitedHealth, the largest private insurer in the U.S., accused
I'm thrilled to sit down with James Maitland, a renowned expert in healthcare mergers and acquisitions with a deep understanding of antitrust regulations and the competitive landscape of the U.S. healthcare industry. With a particular focus on home health and hospice services, James has been
Imagine a healthcare landscape where giant mergers can reshape access to vital services like home health and hospice care overnight, sparking intense debate over competition and consumer choice. A $3.3 billion merger between UnitedHealth and Amedisys, recently settled with the Department of Justice
In a startling revelation that has sent ripples through the scientific and political communities, a recent government watchdog report has exposed illegal actions by the Trump administration in slashing billions of dollars in biomedical research grants managed by the National Institutes of Health
What if a tiny device, no larger than a bandage, could predict a life-threatening heart condition before any symptoms even appear, offering a new lifeline to millions? Across the United States, countless individuals grapple with cardiovascular disease, often unaware of silent risks until it’s too
